Podcast: Download (Duration: 17:37 — 20.2MB) | Embed
Subscribe: Google Podcasts | Spotify | Stitcher | Email | TuneIn | RSS | More
S. Parikh Mars, CEO of Progressive Care Inc. called in to SmallCapVoice.com, Inc. to answer shareholder questions, discuss the impact of recent news about CVS entering the prescription delivery market, provide an update on several fronts and more. Recently, RXMD announced further growth year-over-year in both revenue and number of prescriptions filled for May 2018. The May sales figures come on the heels of some significant company announcements including the launch of a nationwide opioid marketing campaign, the purchase and installation of a new TCGRx pouch packaging system and the initial steps in developing a proprietary tele-pharmacy software.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
About Progressive Care, Inc.
Progressive Care Inc. (OTC QB: RXMD), through PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management (MTM), prescription medications to long term care facilities, and health practice risk management.
This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.